PMID- 10477432 OWN - NLM STAT- MEDLINE DCOM- 19991012 LR - 20061115 IS - 1059-7794 (Print) IS - 1059-7794 (Linking) VI - 14 IP - 3 DP - 1999 TI - Identification of 12 novel mutations and two new polymorphisms in the arylsulfatase A gene: haplotype and genotype-phenotype correlation studies in Spanish metachromatic leukodystrophy patients. PG - 240-8 AB - Arylsulfatase A (ARSA) deficiency is the main cause of metachromatic leukodystrophy (MLD), a lysosomal disorder with no specific treatment. In view of the importance of genetic counseling, analyses of mutations and polymorphisms, including the ARSA pseudodeficiency allele, were carried out in 18 unrelated Spanish MLD patients. A systematic search allowed us to identify 100% of the alleles involving 17 different mutations, 12 of which are novel: G32S, L68P, R84W, P94A, G99V, P136S, W193X, H227Y, R288H, G308D, T327I, and IVS6-12C-->G. Two new polymorphisms, 2033C>T and 2059C>T, were identified in intron 6 which, in combination with two polymorphisms previously described (2161C>G and 2213C>G), gave rise to four different haplotypes in the control population. In addition, we also studied polymorphism 842G>T. Linkage disequilibrium was detected between mutations IVS2+1G-->A, D255H, and T327I and specific haplotypes, suggesting a unique origin for these mutations. Moreover, mutation T327I was always associated with the T allele of the new rare variant A210A (893C>T). The distribution of mutation D255H (frequency 19.4%) among patients with different MLD clinical presentation revealed a clear genotype-phenotype correlation paralleling that reported for mutation IVS2+1G-->A (frequency 25%). Among the novel mutations, only P136S and R288H occurred on a background of the ARSA pseudodeficiency allele. Screening 182 normal chromosomes identified a frequency of 8.8% of this allele; moreover, we identified two unrelated subjects with the polyA- mutation in the absence of the N350S mutation, and this infrequent haplotype reinforced the heterogeneity of conditions with ARSA deficiency. CI - Copyright 1999 Wiley-Liss, Inc. FAU - Gort, L AU - Gort L AD - Institut de Bioquimica Clinica, Barcelona, Spain. FAU - Coll, M J AU - Coll MJ FAU - Chabas, A AU - Chabas A LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Hum Mutat JT - Human mutation JID - 9215429 RN - 0 (Sulfoglycosphingolipids) RN - EC 3.1.6.8 (Cerebroside-Sulfatase) SB - IM MH - Adolescent MH - Adult MH - Age of Onset MH - Alleles MH - Cells, Cultured MH - Cerebroside-Sulfatase/*genetics/metabolism MH - Child MH - Child, Preschool MH - Chromosome Mapping MH - Chromosomes, Human, Pair 22/genetics MH - DNA Mutational Analysis MH - Female MH - Fibroblasts/enzymology MH - Gene Frequency MH - Haplotypes/genetics MH - Humans MH - Infant MH - Leukodystrophy, Metachromatic/diagnosis/*enzymology/genetics MH - Male MH - Mutation MH - Phenotype MH - Polymerase Chain Reaction MH - Polymorphism, Genetic/genetics MH - Polymorphism, Single-Stranded Conformational MH - Spain MH - Sulfoglycosphingolipids/urine EDAT- 1999/09/08 00:00 MHDA- 1999/09/08 00:01 CRDT- 1999/09/08 00:00 PHST- 1999/09/08 00:00 [pubmed] PHST- 1999/09/08 00:01 [medline] PHST- 1999/09/08 00:00 [entrez] AID - 10.1002/(SICI)1098-1004(1999)14:3<240::AID-HUMU7>3.0.CO;2-L [pii] AID - 10.1002/(SICI)1098-1004(1999)14:3<240::AID-HUMU7>3.0.CO;2-L [doi] PST - ppublish SO - Hum Mutat. 1999;14(3):240-8. doi: 10.1002/(SICI)1098-1004(1999)14:3<240::AID-HUMU7>3.0.CO;2-L.